Haleon Company Description

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Haleon plc

Country	United Kingdom
Founded	1715
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	25,408
CEO	Brian McNamara

Contact Details

Address: The Heights Weybridge, KT13 0NY United Kingdom
Phone	44 1932 822000
Website	haleon.com

Stock Details

Ticker Symbol	HLN
Exchange	London Stock Exchange
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BMX86B70
SIC Code	2834

Key Executives

Name	Position
Brian James McNamara	Chief Executive Officer and Executive Director
Tobias Hannes Hestler	Executive Officer
Dawn Amanda Allen	Chief Financial Officer and Director
Claire Dickson	Chief Digital and Technology Officer
Sonya Ghobrial	Head of Investor Relations
Adrian Charles Morris	General Counsel
Tamara Rogers	Chief Marketing Officer
Line De Decker	Chief Human Resources Officer
Filippo Lanzi	President of EMEA and LatAm
Keith Choy	President of Asia Pacific